The global Acromegaly Treatment Market was valued at USD 1.86 billion in 2024 and is projected to reach USD 2.90 billion by 2032, expanding at a compound annual growth rate (CAGR) of 5.71% during the forecast period of 2025–2032. The market is expected to gain momentum as healthcare providers and pharmaceutical innovators accelerate their focus on rare endocrine disorders,...